Location: Home
  • search
  • go
  • Relate News
  • 1/13/2022China Invests in Building Biotech (PharmExec)
  • 1/12/2022Fosun and Insilico Announce a Strategic, AI-driven Drug Discovery and ...
  • 1/12/2022BioNTech Remains Committed to Seeking China Approval for COVID-19 Vacc...
  • 1/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (50th ...
  • 1/11/2022Junshi and Coherus Expand I/O Collaboration to Include TIGIT-Targeted ...
  • 1/11/2022Sana Biotech, IASO Bio and Innovent Announce Non-Exclusive License Dea...
  • 1/11/2022Reuters: Biotech Is Set for a Geopolitical Stress Test
  • 1/11/2022China Healthcare Stocks Post Worst Start in Six Years as Woes Deepen (...
  • 1/11/2022Beijing IP Court Issues "Reference for Case Filing in Civil Cases Invo...
  • 1/11/2022China Solidifies Drug-Buying Programme That Saved $55 Billion
  • 1/10/2022CDE Issues the Technical Guidelines for Clinical Trials of New Anti-Ra...
  • 1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ
  • 1/7/2022Junshi and DotBio to Co-develop Next-Gen Antibody Therapy with DotBody...
  • 1/7/2022Nuance Pharma Acquires Sino Health to Strengthen Commercial Capabiliti...
  • 1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...
  • 1/7/2022CDE Issues the Technical Guidance for Non-Clinical Drug Dependence Res...
  • 1/7/2022CDE Issues the Technical Guidance for Clinical Pharmacokinetic Study o...
  • 1/7/2022CDE Issues the Technical Guidance for Human Bioavailability and Bioequ...
  • 1/7/2022CDE Issues the Guidance Principles for Random Allocation of Drug Clini...
  • 1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China
  • 1/7/2022Drug R&D and Product Registration News Digest January 2022 (1)
  • 1/7/2022Recent Executive Moves
  • 1/6/2022CDE Issues the Technical Guidelines for Preparing the Risk Analysis an...
  • 1/6/2022CDE Issues the Technical Guidelines for Pharmacokinetic Study of Patie...
  • 1/6/2022CDE Issues the Technical Guidance for Clinical Trial Protocols of Drug...
  • 1/6/2022CDE Issues the Technical Guidance for Clinical Research of Rare Diseas...
  • 1/6/2022NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...
  • 1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...
  • 1/5/2022Junshi Biosciences Terminates Promotion Agreement with Astrazeneca
  • 1/5/20223SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...
  • Page:168/789 Total number of articles:23668: [First][<<] [166] [167] [168] [169] [170] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group